268 related articles for article (PubMed ID: 7590497)
21. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
23. Subcutaneous bolus injection of deferoxamine is an alternative method to subcutaneous continuous infusion.
Yarali N; Fişgin T; Duru F; Kara A; Ecin N; Fitoz S; Erden I
J Pediatr Hematol Oncol; 2006 Jan; 28(1):11-6. PubMed ID: 16394886
[TBL] [Abstract][Full Text] [Related]
24. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
25. Update on thalassemia treatment in Taiwan, including bone marrow transplantation, chelation therapy, and cardiomyopathy treatment effects.
Peng CT; Chang JS; Wang LY; Chiou SS; Hsiao CC; Wang SC; Hung GY; Wu KH
Hemoglobin; 2009; 33(5):304-11. PubMed ID: 19814676
[TBL] [Abstract][Full Text] [Related]
26. [Therapeuetic management of patients with thalassemia major].
Thuret I
Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036
[TBL] [Abstract][Full Text] [Related]
27. Unexpected complications after bone marrow transplantation in transfusion-dependent children.
Saunders EF; Olivieri N; Freedman MH
Bone Marrow Transplant; 1993; 12 Suppl 1():88-90. PubMed ID: 8374573
[TBL] [Abstract][Full Text] [Related]
28. Iron chelation by deferoxamine in sickle cell patients with severe transfusion-induced hemosiderosis: a randomized, double-blind study of the dose-response relationship.
Silliman CC; Peterson VM; Mellman DL; Dixon DJ; Hambidge KM; Lane PA
J Lab Clin Med; 1993 Jul; 122(1):48-54. PubMed ID: 8320490
[TBL] [Abstract][Full Text] [Related]
29. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy.
Lucarelli G; Galimberti M; Polchi P; Angelucci E; Baronciani D; Giardini C; Andreani M; Agostinelli F; Albertini F; Clift RA
N Engl J Med; 1993 Sep; 329(12):840-4. PubMed ID: 8355742
[TBL] [Abstract][Full Text] [Related]
30. Management of iron overload with a disposable multi-day delivery system.
Paolo C; Francesco S; Sergio A
Am J Hematol; 1996 Jan; 51(1):95. PubMed ID: 8571948
[No Abstract] [Full Text] [Related]
31. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
Iravani M; Mousavi A; Gholibeikian S; Bahar B; Samiee S; Ashouri A; Eghbal L; Ghavamzadeh A
Bone Marrow Transplant; 2005 Jun; 35(11):1095-9. PubMed ID: 15821773
[TBL] [Abstract][Full Text] [Related]
32. Successful desensitization of a case with desferrioxamine hypersensitivity.
Gülen F; Demir E; Tanaç R; Aydinok Y; Gulen H; Yenigün A; Can D
Minerva Pediatr; 2006 Dec; 58(6):571-4. PubMed ID: 17093379
[TBL] [Abstract][Full Text] [Related]
33. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
34. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy.
Porter JB; Abeysinghe RD; Marshall L; Hider RC; Singh S
Blood; 1996 Jul; 88(2):705-13. PubMed ID: 8695819
[TBL] [Abstract][Full Text] [Related]
36. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.
Byrne JL; Stainer C; Cull G; Haynes AP; Bessell EM; Hale G; Waldmann H; Russell NH
Bone Marrow Transplant; 2000 Feb; 25(4):411-7. PubMed ID: 10723585
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
[TBL] [Abstract][Full Text] [Related]
38. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
[TBL] [Abstract][Full Text] [Related]
39. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
Giardini C; La Nasa G; Contu L; Galimberti M; Polchi P; Angelucci E; Baronciani D; Barbanti I; Muretto P; Lucarelli G
Bone Marrow Transplant; 1993; 12 Suppl 1():108-10. PubMed ID: 8374548
[No Abstract] [Full Text] [Related]
40. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.
Seifert A; von Herrath D; Schaefer K
Q J Med; 1987 Dec; 65(248):1015-24. PubMed ID: 3455553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
